Research Idea
Research content for general circulation. Not individualized advice. Methodology & Disclosures
Q1 2026 showed $27M GAAP net income, $749M revenue, and $40M adjusted EBITDA, with membership up 51% YoY. Positive Medicare Advantage sentiment from the CMS 2027 rate increase and a roughly 46% 21-day rally support near-term upside.
Loading chart data...
AI Analyst Overview
Loading chart data...
Valuation Metrics
Fundamental Analysis
Key Financial Insights: ⢠Profitability Turnaround ⢠Strong Liquidity ⢠Payables Concentration CLOV's quarterly profitability, free-cash-flow turnaround, and strong liquidity improve the outlook, but accumulated losses, payables reliance, and elevated price-to-book warrant caution.
Price Behavior
Key Price Behavior Insights: ⢠Bearish monthly trend ⢠Higher low formation ⢠Key breakout levels Support Level: $4.10â$4.15 Resistance Level: $4.30, then $4.49â$4.60 CLOV remains modestly bearish over the last month but is forming higher lows above $4.10 support; watch for a break below $4.10 or a sustained move above $4.60.
Sentiment & News
Key News Insights: ⢠Membership acceleration ⢠Bonus litigation risk ⢠AI savings Clover Health's strong membership and revenue growth plus AI-driven savings support upside, but unresolved bonus litigation and weaker per-member profitability warrant caution.
AI Summary
CLOV has shifted into an execution-sensitive Medicare Advantage growth story with real profitability and cash-flow momentum, but investors should hold or add only if per-member margins remain durable amid medical-cost pressure and the roughly $120M quality-bonus litigation risk.
Description
Clover Health Investments, Corp. is a U.S. insurer that offers Medicare Advantage products to eligible beneficiaries, delivering plan administration through its Clover Assistant software platform and operating both PPO and HMO plan types. The company also conducts non-insurance activities alongside its core insurance business. Founded in 2014, Clover Health is headquartered in Franklin, Tennessee.
Idea History
| Date | Close | Ticker | Company | Summary | Status | P/L |
|---|---|---|---|---|---|---|
| May 7 | May 14 | CLOV | Clover Health Investments, Corp. | Q1 2026 showed $27M GAAP net income, $749M revenue, and $40M adjusted EBITDA, with membership up 51% YoY. Positive Medicare Advantage sentiment from the CMS 2027 rate increase and a roughly 46% 21-day rally support near-term upside. | Closed | +23.8% |